3 No-Brainer Stocks to Buy With $300 Right Now
3 No-Brainer Stocks to Buy With $300 Right Now
Investing in shares can help you build wealth in the long term, although it comes with inherent risks. Nonetheless, some stocks are considered âno-brainersâ due to their fundamentally strong business models, solid financials, and potential for long-term growth. These companies have demonstrated resilience and adaptability in all market conditions, making them ideal choices for long-term investors.
從長遠來看，投資股票可以幫助你積累財富，儘管它有固有的風險。儘管如此，由於其基本強勁的商業模式、穩健的財務狀況和長期增長的潛力，一些股票被認爲是 “不費吹灰之力”。這些公司在所有市場條件下都表現出了彈性和適應能力，使其成爲長期投資者的理想選擇。
So, if you plan to invest in stocks with $300, here are three no-brainer Canadian stocks to consider.
因此，如果你計劃投資300美元的股票，這裏有三隻不費吹灰之力的加拿大股票可供考慮。
No-brainer stock #1
不費吹灰之力的股票 #1
Speaking of no-brainer stocks, investors could consider investing in goeasy (TSX:GSY) for its solid financials and long-term growth potential. This financial services company is an industry leader in Canadaâs non-prime lending sector. What stands out is that goeasy has consistently grown its revenue and earnings per share (EPS) at a solid double-digit rate, which has driven its share price and dividend distributions.
說到不費吹灰之力的股票，投資者可以考慮投資goeasy（多倫多證券交易所股票代碼：GSY），因爲其穩健的財務狀況和長期增長潛力。這家金融服務公司是加拿大非優先貸款領域的行業領導者。最引人注目的是，goeasy一直以穩定的兩位數增長率持續增長其收入和每股收益（EPS），這推動了其股價和股息分配。
goeasyâs top line sports a compound annual growth rate (CAGR) of 20% in the last five years. At the same time, its EPS increased at a CAGR of 32.2%. Thanks to its stellar financials, goeasy stock has grown at a CAGR of nearly 34% in the last five years, delivering capital gains of about 332%. Moreover, it enhanced its shareholdersâ returns via higher dividend payments during the same time.
goeasya的收入在過去五年中複合年增長率（CAGR）爲20％。同時，其每股收益以32.2％的複合年增長率增長。得益於其出色的財務狀況，goeasy股票在過去五年中以近34％的複合年增長率增長，資本收益約爲332％。此外，它通過在同一時期增加股息來提高股東的回報。
The momentum in goeasyâs business is likely to sustain in the coming years, driven by a large addressable market, omnichannel offerings, geographical expansion, and wide product range. These factors will drive goeasyâs loans and overall revenues. Further, the companyâs solid credit underwriting capabilities and focus on operating efficiency will likely cushion its earnings and dividend payments.
在龐大的潛在市場、全渠道產品、地域擴張和廣泛的產品範圍的推動下，goeasya的業務勢頭可能會在未來幾年持續下去。這些因素將推動goeasya的貸款和總收入。此外，該公司穩健的信貸承保能力和對運營效率的關注可能會緩衝其收益和股息支付。
Despite the uptrend in goeasy stock, it is still trading at the next 12-month (NTM) price-to-earnings multiple of 11.2, which is attractive given its higher EPS growth and a decent yield of 2.3%.
儘管goeasy股票呈上升趨勢，但其交易價格仍爲未來12個月（NTM）11.2的市盈倍數，鑑於其更高的每股收益增長和2.3％的不錯收益率，這具有吸引力。
No-brainer stock #2
不費吹灰之力的股票 #2
WELL Health (TSX:WELL) is a leading digital healthcare company and the largest owner-operator of outpatient medical clinics in Canada. The company is growing rapidly and delivering solid financials. Moreover, WELL stock is trading cheap on the valuation front, providing an excellent opportunity for investing.
WELL Health（多倫多證券交易所股票代碼：WELL）是一家領先的數字醫療保健公司，也是加拿大最大的門診所有者兼運營商。該公司發展迅速，財務狀況良好。此外，WELL股票在估值方面交易價格低廉，爲投資提供了絕佳的機會。
The momentum in WELL Healthâs business will likely continue in 2024 and beyond, driven by higher omnichannel patient visits. Moreover, its focus on accretive acquisitions will likely accelerate its growth. Additionally, WELL Health is optimizing operations to enhance organic growth and profitability. By prioritizing capital-efficient growth opportunities, the company aims to leverage its cash flows to reduce debt and limit share issuance.
在全渠道患者就診人數增加的推動下，WELL Healtha的業務勢頭可能會在2024年及以後持續下去。此外，其對增值收購的關注可能會加速其增長。此外，WELL Health正在優化運營，以提高有機增長和盈利能力。通過優先考慮資本效率的增長機會，該公司的目標是利用其現金流來減少債務和限制股票發行。
In Canada, WELL Health is set to strengthen its market leadership as the nationâs first pan-Canadian clinical network. Further, it has implemented a cost optimization program to enhance operational efficiency and profitability. Furthermore, WELL Health is investing in artificial intelligence (AI) technologies to develop new products that will support its growth.
在加拿大，作爲加拿大第一個泛加拿大臨床網絡，WELL Health將加強其市場領導地位。此外，它還實施了成本優化計劃，以提高運營效率和盈利能力。此外，WELL Health正在投資人工智能（AI）技術，以開發支持其增長的新產品。
No-brainer stock #3
不費吹灰之力的股票 #3
Alimentation Couche-Tard (TSX:ATD) stock could be a solid addition to your portfolio. This company operates convenience stores, a defensive business known for its resilience and stability. The firm also engages in fuel retailing and provides electric vehicle (EV) charging.
Alimentation Couche-Tard（多倫多證券交易所股票代碼：ATD）的股票可能是您投資組合的可靠補充。該公司經營便利店，這是一家以其彈性和穩定性而聞名的防禦性企業。該公司還從事燃料零售並提供電動汽車（EV）充電。
Couche-Tard has a proven track record of delivering robust earnings and consistently outperforming the broader market. Over the past decade, the companyâs adjusted EPS has grown at an impressive CAGR of 15.2%. This strong earnings growth has enabled the company to increase its dividends at a CAGR of 25.6% during the same period. Couche-Tard stock has grown at a CAGR of 16.6% over the last five years, translating into an overall capital gain of more than 115%.
Couche-Tard在提供強勁收益和持續跑贏整個市場方面有着良好的記錄。在過去的十年中，該公司調整後的每股收益以令人印象深刻的15.2％的複合年增長率增長。這種強勁的收益增長使該公司能夠在同期以25.6％的複合年增長率增加股息。在過去五年中，Couche-Tard的股票以16.6％的複合年增長率增長，總資本收益超過115％。
Couche-Tardâs extensive network of stores, the expansion of its private label products, and operating leverage will likely drive its financials. Furthermore, the companyâs solid balance sheet and ability to acquire and integrate companies will accelerate its growth rate and drive its share price and dividends.
Couche-Tarda龐大的門店網絡、其自有品牌產品的擴張和運營槓桿率可能會推動其財務狀況。此外，該公司穩健的資產負債表以及收購和整合公司的能力將加速其增長率並推動其股價和股息。
The post 3 No-Brainer Stocks to Buy With $300 Right Now appeared first on The Motley Fool Canada.
《立即用300美元買入的三隻不費吹灰之力的股票》一文首次出現在《加拿大Motley Fool》上。